title: Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified.
authors.affiliation: Queen Mary's University of London, London E1 4AT, UK g.r.foster@qmul.ac.uk.
authors.forename: Graham R
authors.initials: GR
authors.lastname: Foster
authors.affiliation: Hepatitis C Trust, London, UK.
authors.forename: Charles
authors.initials: C
authors.lastname: Gore
authors.affiliation: BASL (British Association for the Study of the Liver), Lichfield, UK.
authors.forename: Mark
authors.initials: M
authors.lastname: Hudson
authors.affiliation: British Infection Association (BIA), Knutsford, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Moss
authors.affiliation: British Viral Hepatitis Group (BVHG), Lichfield, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Ustianowski
authors.affiliation: British Society of Gastroenterology (BSG), London, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Ryder
authors.affiliation: BHIVA Hepatitis Society, London, UK.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Bhagani
mesh_terms: D006526:Hepatitis C / Q000175:diagnosis*; D006801:Humans; D008403:Mass Screening / Q000379:methods*